ArticleSurgical neurology international2025
Autoimmune hypophysitis associated with rheumatoid arthritis: Histopathological insights from a rare biopsy-proven case.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autoimmune hypophysitis (AH), an uncommon inflammatory disorder of the pituitary gland, involves immune cell infiltration into pituitary tissue and often occurs concurrently with systemic autoimmune diseases. Although Hashimoto's thyroiditis, systemic lupus erythematosus, and IgG4-related disease have been associated with AH, rheumatoid arthritis (RA)-associated AH remains exceedingly rare, particularly in seropositive cases. Clinical and imaging characteristics of AH mimic a wide range of infectious, neoplastic, and infiltrative pathologies. Biopsy remains the gold standard for definitive diagnosis, though it is rarely pursued. Methods: A retrospective chart review was performed to obtain the details regarding patient history, histopathological findings, and treatment course. Results: This rare case of biopsy-proven AH involved a 46-year-old female with seropositive RA. The patient presented with progressive headaches, small scotomas in both visual fields, and multiple endocrinopathies including central hypothyroidism and adrenal insufficiency. Magnetic resonance imaging revealed an infiltrative, contrast-enhancing suprasellar lesion. Surgical intervention was pursued for biopsy and debulking. Histopathology demonstrated pituitary tissue infiltrated by a heterogeneous population of inflammatory cells without evidence of well-formed granulomas. In the context of positive rheumatoid factor (RF) and anticyclic citrullinated peptide antibodies, the diagnosis of RA-associated AH was favored. The patient was treated with azathioprine with resolution of her headaches and scotomas and radiographic improvement. To our knowledge, this case represents the first biopsy-proven example of seropositive RA-associated AH. Conclusion: This case underscores the importance of maintaining a broad differential diagnosis when evaluating pituitary lesions, especially in patients with systemic autoimmune disorders, and highlights the role of tissue diagnosis and decompression in a symptomatic patient with a suprasellar lesion resulting in mass effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.